{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:07Z","timestamp":1759334827251,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jaad.2016.12.015","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T11:34:45Z","timestamp":1489750485000},"page":"772-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Disease modification for hidradenitis suppurativa: A new paradigm"],"prefix":"10.1016","volume":"76","author":[{"given":"So Yeon","family":"Paek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. William","family":"Danby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar A.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.12.015_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00403-015-1613-8","article-title":"Patient-relevant treatment\u00a0goals in psoriasis","volume":"308","author":"Blome","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2016.12.015_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2500\/aap.2014.35.3798","article-title":"Atopic dermatitis: the updated practice parameter and beyond","volume":"35","author":"Boguniewicz","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaad.2016.12.015_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10787-015-0232-5","article-title":"A history of the term \u201cDMARD\u201d","volume":"23","author":"Buer","year":"2015","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.jaad.2016.12.015_bib4","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/rheumatology\/kei024","article-title":"The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database","volume":"44","author":"Edwards","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2016.12.015_bib5","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2877","article-title":"A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis","volume":"11","author":"Le Goff","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"suppl 6","key":"10.1016\/j.jaad.2016.12.015_bib6","doi-asserted-by":"crossref","first-page":"vi28","DOI":"10.1093\/rheumatology\/kes278","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51","author":"Upchurch","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2016.12.015_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/s10165-008-0114-4","article-title":"Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging","volume":"19","author":"Hirose","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2016.12.015_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaad.2016.12.015_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40257-014-0105-5","article-title":"Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study","volume":"16","author":"Alavi","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"5 suppl 1","key":"10.1016\/j.jaad.2016.12.015_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5 suppl 1","key":"10.1016\/j.jaad.2016.12.015_bib11","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.015_bib12","article-title":"Development of a quality-of-life measure for hidradenitis suppurativa","author":"Sisic","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2016.12.015_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","article-title":"The handicap of hidradenitis suppurativa","volume":"34","author":"Deckers","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2016.12.015_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00128071-200102030-00002","article-title":"Optimal management of acne to prevent scarring and psychological sequelae","volume":"2","author":"Layton","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"3 suppl","key":"10.1016\/j.jaad.2016.12.015_bib15","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.12788\/j.sder.0093","article-title":"Recognizing and managing comorbidities and complications in hidradenitis suppurativa","volume":"33","author":"Menter","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2016.12.015_bib16","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1542\/peds.2012-3356","article-title":"Residual scarring from hidradenitis suppurativa: fractionated CO2 laser as a novel and noninvasive approach","volume":"133","author":"Krakowski","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2016.12.015_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.015_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:41:12Z","timestamp":1759272072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216312397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0190962216312397"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease modification for hidradenitis suppurativa: A new paradigm","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}